Skip to main content
. Author manuscript; available in PMC: 2025 Feb 4.
Published in final edited form as: Curr Top Microbiol Immunol. 2019;420:211–231. doi: 10.1007/82_2018_137

Fig. 6.

Fig. 6

Major structural interactions of known PARP inhibitors with the NAD+ binding pocket. Crystal structures of known PARP inhibitors demonstrate how various small molecules can exploit different features in the nicotinamide and adenosine subsites in the NAD+ binding pocket